PT65946A - Process for the manufacture of glucosamine derivatives - Google Patents

Process for the manufacture of glucosamine derivatives

Info

Publication number
PT65946A
PT65946A PT65946A PT6594676A PT65946A PT 65946 A PT65946 A PT 65946A PT 65946 A PT65946 A PT 65946A PT 6594676 A PT6594676 A PT 6594676A PT 65946 A PT65946 A PT 65946A
Authority
PT
Portugal
Prior art keywords
manufacture
glucosamine derivatives
glucosamine
derivatives
Prior art date
Application number
PT65946A
Other languages
Portuguese (pt)
Other versions
PT65946B (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT65946A publication Critical patent/PT65946A/en
Publication of PT65946B publication Critical patent/PT65946B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT65946A 1975-12-10 1976-12-09 Process for the manufacture of glucosamine derivatives PT65946B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (2)

Publication Number Publication Date
PT65946A true PT65946A (en) 1977-01-01
PT65946B PT65946B (en) 1978-06-14

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
PT65946A PT65946B (en) 1975-12-10 1976-12-09 Process for the manufacture of glucosamine derivatives

Country Status (30)

Country Link
JP (1) JPS5273820A (en)
AR (2) AR224091A1 (en)
AT (1) AT365607B (en)
AU (1) AU508764B2 (en)
BE (1) BE849214A (en)
CA (1) CA1262400A (en)
CH (2) CH613709A5 (en)
CS (4) CS205026B2 (en)
DD (1) DD129781A5 (en)
DE (1) DE2655500A1 (en)
DK (1) DK154654C (en)
ES (2) ES454118A1 (en)
FI (1) FI64164C (en)
FR (1) FR2361902A1 (en)
GB (1) GB1570625A (en)
GR (1) GR61647B (en)
HK (1) HK32883A (en)
HU (1) HU177970B (en)
IE (1) IE44190B1 (en)
IL (1) IL51076A (en)
MY (1) MY8400123A (en)
NL (1) NL7613666A (en)
NO (1) NO144850C (en)
NZ (1) NZ182837A (en)
PL (4) PL110787B1 (en)
PT (1) PT65946B (en)
SE (1) SE445923B (en)
SG (1) SG11083G (en)
SU (3) SU660589A3 (en)
ZA (1) ZA767333B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
FR2442241A2 (en) * 1978-03-20 1980-06-20 Anvar NOVEL ESTER COMPOUNDS OF MURAMYL-PEPTIDE, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, IN PARTICULAR IN THE FORM OF LIPOSOMES
FR2420545A1 (en) * 1978-03-20 1979-10-19 Anvar NEW ESTERS OF N-ACETYL-MURAMYL-AMINOACYL-GLUTAMIC ACID OR SUBSTITUTION DERIVATIVES THEREOF WITH ANTI-INFECTIOUS PROPERTIES AND / OR IMMUNOLOGICAL ADJUVANTS
FR2428050A1 (en) * 1978-06-05 1980-01-04 Anvar OLIGOMERS OF MURAMYL-PEPTIDE COMPOUNDS AND DRUGS CONTAINING THEM
FR2428051A1 (en) * 1978-06-05 1980-01-04 Anvar NOVEL MURAMYL-PEPTIDE COMPOUNDS AND MEDICAMENTS CONTAINING THEM
FR2446292A1 (en) * 1979-01-12 1980-08-08 Anvar MURAMYL-PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (en) 1979-02-20 1980-09-19 Anvar NOVEL MURAMYL-PEPTIDES SUBSTITUTED ON PEPTIDE NITROGEN AND MEDICAMENTS CONTAINING THEM
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (en) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogous procedure for the preparation of pharmacologically acting lipophilic a phosphatidylmuramyl peptides.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (en) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FI803077A (en) 1979-10-12 1981-04-13 Ciba Geigy Ag FOERFARANDE FOER FRAMSTAELLNING AV MYRAMYLPEPTIDER
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (en) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics
GR78246B (en) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (en) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka Muramyldipeptide active ester derivative
EP0541486A1 (en) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclic conjugates
WO2006118327A1 (en) * 2005-04-27 2006-11-09 Oxygenix Co Ltd Cationic amino acid type lipid
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
MX2020002010A (en) 2017-08-21 2020-07-13 Celgene Corp Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopent anoate.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
AR220686A1 (en) 1980-11-28
FI64164B (en) 1983-06-30
ZA767333B (en) 1977-11-30
DK154654C (en) 1989-05-08
CH613709A5 (en) 1979-10-15
SU747430A3 (en) 1980-07-23
FR2361902B1 (en) 1980-11-07
DK552476A (en) 1977-06-11
IE44190B1 (en) 1981-09-09
CS205028B2 (en) 1981-04-30
SG11083G (en) 1983-09-16
SE7613851L (en) 1977-06-11
DD129781A5 (en) 1978-02-08
PL110353B1 (en) 1980-07-31
PT65946B (en) 1978-06-14
FR2361902A1 (en) 1978-03-17
PL194291A1 (en) 1978-10-23
MY8400123A (en) 1984-12-31
AT365607B (en) 1982-02-10
NL7613666A (en) 1977-06-14
DE2655500C2 (en) 1988-12-22
FI763541A (en) 1977-06-11
ATA909276A (en) 1981-06-15
PL110787B1 (en) 1980-07-31
ES454118A1 (en) 1978-03-01
NO144850C (en) 1981-11-25
PL110794B1 (en) 1980-07-31
HK32883A (en) 1983-09-02
NZ182837A (en) 1978-07-28
CS205025B2 (en) 1981-04-30
CS205027B2 (en) 1981-04-30
CS205026B2 (en) 1981-04-30
DE2655500A1 (en) 1977-06-23
AR224091A1 (en) 1981-10-30
DK154654B (en) 1988-12-05
IL51076A (en) 1980-09-16
FI64164C (en) 1983-10-10
IE44190L (en) 1977-06-10
CA1262400A (en) 1989-10-17
BE849214A (en) 1977-06-09
JPS638118B2 (en) 1988-02-19
PL112672B1 (en) 1980-10-31
IL51076A0 (en) 1977-02-28
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
AU508764B2 (en) 1980-04-03
JPS5273820A (en) 1977-06-21
SU660589A3 (en) 1979-04-30
HU177970B (en) 1982-02-28
ES465514A1 (en) 1978-09-16
SE445923B (en) 1986-07-28
AU2042276A (en) 1978-06-15
SU1060118A3 (en) 1983-12-07
CH614718A5 (en) 1979-12-14
NO144850B (en) 1981-08-17
NO764191L (en) 1977-06-13

Similar Documents

Publication Publication Date Title
PT65946A (en) Process for the manufacture of glucosamine derivatives
YU39479B (en) Process for the manufacture of thieno-pyridine derivatives
GB1547802A (en) Process for the preparation of poly-phenyleneterephthalamide
GB1542442A (en) Process for the manufacture of nucleosides
HU171396B (en) Process for preparing derivatives of the rifamycine
PT65486A (en) Process for the preparation of carbonil-substituted 1-sulfonylbenzimidazoles
GB1517423A (en) Process for the preparation of diaryl-carbonates
HU171395B (en) Process for preparing derivatives of the rifamycine
PT65255B (en) Process for the preparation of 11-desoxy-16-aryloxy-w-tetranorprostaglandins
CH608786A5 (en) Process for the preparation of acetoacetylarylamides
GB1534077A (en) Process for the preparation of 5-acetoacetylamino-benzimidazolone
YU187776A (en) Process for prepring derivatives of diaminoandrostane
GB1520681A (en) Process for the production of phoroglucinol
ZA76474B (en) Process for the preparation of thienopyridine derivatives
GB1551120A (en) Process for the manufacture of 16-20-keto-steroids
PT65120A (en) Process for the preparation of novel diureide derivatives
GB1548670A (en) Pricess for the production of 2-amino-3-hydroxypyridines
ZA763221B (en) Process for the preparation of 3-bromobenzalidehyde
GB1477990A (en) Process for the preparation of thieno-pyridine derivatives
GB1543390A (en) Process for the production of 2-amino-3-hydroxypyridine derivatives
CH613691A5 (en) Process for the preparation of novel 1-indolinylguanidine derivatives
HU172451B (en) Process for preparing derivatives of the beta-nitro-pyrazole
GB1546087A (en) Process for the manufacture of hydrazobenzene derivatives
PT65357A (en) Process for the preparation of gammapyrones
PT65176A (en) Process for the preparation of 6-amino-methylated 3-oxygenated cholest-5-enes